Vendor, Spring, TX
Eisana Corp.
UEI LUW6W9WL7CX5, CAGE 8HM61
1 award and $0 obligated between May 2, 2024 and July 24, 2024, 100% under full and open competition, against 2.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91023C00036Definitive Contract, May 2, 2024, Full and Open Competition After Exclusion of Sources, 2 offers | NIH NCINational Institutes of Health | Topic 447: Development and Testing of a Non-Invasive Cryo-Device to Prevent Chemotherapy-Induced Peripheral Neuropathy in Hands and Feet of NAICS 541715, PSC AN12 | $0 |
- Places of performance
- Texas
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards